K M Davidson|P Tyrer - JoVE Visualize

Showing results (181-190 of 283) with videos related to

Pageof 29

Sort By:

Journal of Intellectual Disability Research : JIDR|February 27, 2003

Preliminary evaluation of a scale to assess cognitive function in adults with Down's syndrome: the Prudhoe Cognitive Function TestD W K Kay, S P Tyrer, M L Margallo-Lana, et al.

Lancet (London, England)|July 30, 1988

The Nottingham study of neurotic disorder: comparison of drug and psychological treatmentsP Tyrer, N Seivewright, S Murphy, et al.

Psychological Medicine|May 7, 2002

Heavy users of acute psychiatric beds: randomized controlled trial of enhanced community management in an outer London boroughP Harrison-Read, B Lucas, P Tyrer, et al.

Journal of Intellectual Disability Research : JIDR|June 22, 2005

Randomized controlled trial of assertive community treatment in intellectual disability: the TACTILD studyP C Oliver, J Piachaud, P Tyrer, et al.

Lancet (London, England)|March 25, 1995

A randomised controlled study of close monitoring of vulnerable psychiatric patientsP Tyrer, J Morgan, E Van Horn, et al.

ERJ Open Research|October 6, 2021

Outcomes and characteristics of COVID-19 patients treated with continuous positive airway pressure/high-flow nasal oxygen outside the intensive care settingDominic L Sykes, Michael G Crooks, Khaing Thu Thu, et al.

Journal of Intellectual Disability Research : JIDR|May 12, 2007

Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathologyM L Margallo-Lana, P B Moore, D W K Kay, et al.

HGG Advances|November 28, 2025

S4-multi: Enhancing polygenic score prediction in ancestrally diverse populationsJohn Baierl, Jonathan P Tyrer, Ping-Hung Lai, et al.

Neuroreport|June 27, 1994

Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21)R Raghavan, C Khin-Nu, A G Brown, et al.

European Journal of Pharmacology|December 12, 1996

L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assaysG R Seabrook, S L Shepheard, D J Williamson, et al.

Pageof 29

Showing results (181-190 of 283) with videos related to

Sort By:

Pageof 29

Journal of Intellectual Disability Research : JIDR|February 27, 2003

Preliminary evaluation of a scale to assess cognitive function in adults with Down's syndrome: the Prudhoe Cognitive Function TestD W K Kay, S P Tyrer, M L Margallo-Lana, et al.

Lancet (London, England)|July 30, 1988

The Nottingham study of neurotic disorder: comparison of drug and psychological treatmentsP Tyrer, N Seivewright, S Murphy, et al.

Psychological Medicine|May 7, 2002

Heavy users of acute psychiatric beds: randomized controlled trial of enhanced community management in an outer London boroughP Harrison-Read, B Lucas, P Tyrer, et al.

Journal of Intellectual Disability Research : JIDR|June 22, 2005

Randomized controlled trial of assertive community treatment in intellectual disability: the TACTILD studyP C Oliver, J Piachaud, P Tyrer, et al.

Lancet (London, England)|March 25, 1995

A randomised controlled study of close monitoring of vulnerable psychiatric patientsP Tyrer, J Morgan, E Van Horn, et al.

ERJ Open Research|October 6, 2021

Outcomes and characteristics of COVID-19 patients treated with continuous positive airway pressure/high-flow nasal oxygen outside the intensive care settingDominic L Sykes, Michael G Crooks, Khaing Thu Thu, et al.

Journal of Intellectual Disability Research : JIDR|May 12, 2007

Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathologyM L Margallo-Lana, P B Moore, D W K Kay, et al.

HGG Advances|November 28, 2025

S4-multi: Enhancing polygenic score prediction in ancestrally diverse populationsJohn Baierl, Jonathan P Tyrer, Ping-Hung Lai, et al.

Neuroreport|June 27, 1994

Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21)R Raghavan, C Khin-Nu, A G Brown, et al.

European Journal of Pharmacology|December 12, 1996

L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assaysG R Seabrook, S L Shepheard, D J Williamson, et al.

Pageof 29